marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-14-2022
Opiant Pharmaceuticals Financial Statements 2011-2024 | OPNT
Annual Financial Statements Opiant Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
116 M | 45.7 M | 51 M | 46.9 M | 62.3 M | 13.9 M | 13.1 M | 87.4 K | 100 K | 1.56 M | 356 K |
Shares |
4.46 M | 4.26 M | 4.02 M | 2.99 M | 2.01 M | 1.91 M | 1.81 M | 1.75 M | 1.43 M | 22.2 M | 672 K |
Historical Prices |
26.2 | 12.7 | 11.8 | 15.3 | 21.4 | 7.9 | 9.01 | 10.2 | 0.05 | 0.05 | 0.08 |
Net Income |
3.01 M | -1.86 M | 11.6 M | -21.2 M | 6.58 M | -7.81 M | -7.04 M | -11.5 M | -4.66 M | 18.3 M | -9.44 M |
Revenue |
47.8 M | 29.6 M | 40.5 M | 14 M | 18.4 M | 9.9 M | 1.55 M | - | - | 173 M | - |
Cost of Revenue |
- | - | - | 13.7 M | - | - | - | - | - | - | - |
Gross Profit |
- | 23.4 M | 32.8 M | 12.5 M | - | - | 1.55 M | - | - | 134 M | - |
Operating Income |
5.16 M | -2.24 M | 10.9 M | -21.2 M | -1.88 M | -7.74 M | -6.9 M | -11.3 M | -8.81 M | -12.3 M | -9.44 M |
Interest Expense |
2.13 M | 131 K | - | 145 K | 20 K | -11.9 K | 28.2 K | 160 K | 553 K | 61.4 K | - |
EBITDA |
5.25 M | -1.63 M | 11.1 M | -21.2 M | 7.1 M | -7.74 M | -6.9 M | -11.3 M | -4.28 M | 34.3 M | -9.43 M |
Operating Expenses |
42.6 M | 25.7 M | 21.9 M | 33.7 M | 11.4 M | 17.6 M | 8.45 M | 11.3 M | 4.28 M | 106 M | 9.44 M |
General and Administrative Expenses |
12.2 M | 11.7 M | 12.2 M | 11.3 M | 6.53 M | 15.6 M | 6.03 M | 10.8 M | 4 M | -42.5 M | 9.44 M |
All numbers in USD currency
Quarterly Income Statement Opiant Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 5.14 M | 5.09 M | 5.02 M | 4.91 M | 4.46 M | 4.33 M | 4.28 M | 4.26 M | 4.26 M | 4.26 M | 4.22 M | 4.19 M | 4.05 M | 4 M | 3.91 M | 3.85 M | 2.87 M | 2.68 M | 2.54 M | 2.01 M | 2.03 M | 2.02 M | 2.01 M | 1.88 M | 1.88 M | 1.87 M | 1.92 M | 1.81 M | 1.8 M | 1.8 M | 1.83 M | 1.71 M | 1.79 M | 1.72 M | 179 M | 132 M | 166 M | 130 M | 133 M | 92.8 M | 128 M | 92.8 M | 97.9 M | 62.7 M | 84.9 M | 62.7 M | 84.9 M |
Net Income |
- | -9.92 M | -11.7 M | -12.2 M | - | 3.42 M | 1.68 M | -2.84 M | - | 725 K | -216 K | -1.68 M | - | 10.7 M | 1.58 M | -1.74 M | - | -918 K | -1.4 M | -9.34 M | 10.6 M | -3.41 M | 239 K | -5.63 M | 3.97 M | -601 K | -7.14 M | -601 K | -2.78 M | -11.1 M | -3.55 M | -11.1 M | -5.06 M | -775 K | -6.77 M | -775 K | -6.29 M | -1.71 M | -7.15 M | -1.71 M | -4.58 M | -857 K | -9.3 M | -1.1 M | -995 K | -4.72 M | -9.44 M | -4.72 M |
Revenue |
- | 174 K | 3.89 M | 4.47 M | - | 16.3 M | 11.3 M | 6.39 M | - | 9.11 M | 6.31 M | 4.28 M | - | 20.6 M | 6.77 M | 5.44 M | - | 4.37 M | 3.15 M | 1.7 M | 13.5 M | 22 K | 3.77 M | 22 K | 6.86 M | 1.12 M | 6.98 M | 1.12 M | 560 K | 120 K | 560 K | 120 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -9.63 M | -11.4 M | -11.8 M | - | 3.96 M | 2.25 M | -2.32 M | - | 727 K | -232 K | -1.72 M | - | 10.6 M | 1.41 M | -1.83 M | - | -940 K | -1.32 M | -9.31 M | 10.6 M | -2.84 M | 211 K | -5.61 M | 4 M | -579 K | -7.1 M | -579 K | -2.77 M | -11.1 M | -3.53 M | -11.1 M | -5.09 M | -760 K | -6.63 M | -760 K | -6.24 M | -1.54 M | -6.97 M | -1.54 M | -4.57 M | -733 K | -9.28 M | -972 K | -995 K | -4.71 M | -1.28 M | -4.71 M |
Interest Expense |
- | 391 K | 401 K | 421 K | - | 547 K | 542 K | 537 K | - | - | - | - | - | 112 K | 123 K | 122 K | - | 20 K | 6 K | 5 K | 877 | 7 K | 12 K | 7 K | 5.49 K | -2 K | -11.3 K | -2.24 K | 19.4 K | 5.83 K | 27.6 K | 4.1 K | 6.24 K | 8.21 K | 132 K | 8.21 K | 109 K | 126 K | 255 K | 126 K | 3 K | 145 K | 3.73 K | 145 K | - | 13.5 K | - | 13.5 K |
EBITDA |
- | -9.6 M | -11.3 M | -11.8 M | - | 4.04 M | 2.31 M | -2.29 M | - | 819 K | -171 K | -1.68 M | - | 10.6 M | 1.41 M | -1.83 M | - | -938 K | -1.32 M | -9.31 M | 10.6 M | -2.84 M | 214 K | -5.6 M | 4 M | -578 K | -7.1 M | -578 K | -2.77 M | -11.1 M | -3.53 M | -11.1 M | -5.09 M | -760 K | -6.63 M | -760 K | -6.24 M | -1.54 M | -6.97 M | -1.54 M | -4.57 M | -733 K | -9.28 M | -971 K | -995 K | -4.71 M | -1.28 M | -4.71 M |
Operating Expenses |
- | 9.8 M | 15.3 M | 16.3 M | - | 12.4 M | 9.01 M | 8.71 M | - | 8.38 M | 6.54 M | 6 M | - | 10 M | 5.36 M | 7.26 M | - | 5.31 M | 4.47 M | 11 M | 2.9 M | 2.87 M | 3.56 M | 5.63 M | 2.86 M | 1.7 M | 14.1 M | 1.7 M | 3.33 M | 11.2 M | 4.09 M | 11.2 M | 5.09 M | 760 K | 6.63 M | 760 K | 6.24 M | 1.54 M | 6.97 M | 1.54 M | 4.57 M | 733 K | 9.28 M | 972 K | 995 K | 4.71 M | 1.28 M | 4.71 M |
General and Administrative Expenses |
- | 3.07 M | 4.01 M | 4.33 M | - | 3.38 M | 2.73 M | 2.65 M | - | 2.73 M | 2.84 M | 2.57 M | - | 3.21 M | 2.8 M | 3.38 M | - | 2.86 M | 2.86 M | 2.96 M | 1.36 M | 2.18 M | 1.85 M | 4.02 M | 2.39 M | 1.22 M | 13 M | 1.22 M | 2.14 M | 10.8 M | 2.85 M | 10.8 M | 5.06 M | 708 K | 6.54 M | 708 K | 6.17 M | 1.48 M | 6.82 M | 1.48 M | 4.52 M | 684 K | 8.92 M | 923 K | 995 K | 4.41 M | 1.28 M | 4.71 M |
All numbers in USD currency